HIPRA participated as a sponsor in the 43rd ASESCU Cuniculture Symposium last May, which was held in Calamocha (Aragón). As part of the congress, Dr. Almudena Sánchez-Matamoros (Researcher in UCAM, HIPRA), gave an oral presentation on “Post-vaccination efficacy studies for the prevention of the new variant RHD”.

During her presentation, Mrs. Sánchez-Matamoros exposed the main results of a study whose  objective was to evaluate the efficacy of vaccination with ERAVAC^® (inactivated vaccine against rabbit haemorrhagic disease type 2) in rabbits for up to 12 months post-vaccination.

These results improve our vaccination knowledge for designing both annual revaccination and emergency vaccination programmes against RHD-2.

With this initiative, HIPRA demonstrates its support for the rabbit industry and affirms its commitment to the prevention of RHD-2.